This underscores that transient, short‐term intrafollicular G1 arrest by topical application of CDK4/6 inhibitors, rather than prolonged G1 arrest by systemic agents, is the most promising strategy to obtain the desired anti‐chemotherapy‐induced alopecia effect. Here, CDK4 is linked to alopecia.